Home/Etcembly/Michelle Teng
MT

Michelle Teng

CEO & Co-founder

Etcembly

Therapeutic Areas

Etcembly Pipeline

DrugIndicationPhase
Zelluna TCR-NK Candidate (Platform-Optimized)Not Specified (Likely Oncology)Pre-clinical